Otsuka acquired AVP-786 from CNS specialist Avanir Pharmaceuticals in a 2015 buyout worth $3.5 billion. Also coming in that ...

When it comes to supporting cancer care and other therapeutic approaches in low- and middle-income countries (LMICs), Bristol ...

The more than 53,000 women in the U.S. who have filed injury lawsuits against Johnson & Johnson have added ammunition for ...

Merck KGaA’s North American life science division, MilliporeSigma, has made U.S. legal history thanks to its swift and ...

Another fire broke out at a Novo Nordisk facility on Wednesday, marking the second fire at one of the drugmaker's sites in ...

Though many pharmas have grand plans for digital disruption across their businesses, those plans are being disrupted ...

Asymchem Laboratories is expanding its global footprint by taking on Pfizer’s leftovers in Sandwich, England. | Pfizer ...

Three years into a Senate Finance Committee investigation into Big Pharma’s tax strategies, committee chair Ron Wyden, ...

As Incyte Corporation continues its growth momentum thanks to JAK inhibitors Jakafi and Opzelura, the company is bringing its ...

A new survey from Dexcom suggests that living with Type 2 diabetes can have significant impacts not only on physical health ...

Even as GSK defends itself against thousands of personal injury lawsuits relating to its sale of heartburn pill Zantac, a ...

Havas is rebranding its health network, launching new global agencies as part of a reshuffle that will put most of its groups ...